It is anticipated that the noninvasive imaging of the expression of the AT1 receptor using radiolabeled AngII peptide analog would facilitate the timely diagnosis of breast cancer and possible monitoring of cancer treatment efficacy. This evidence concerns the gene AGT and breast carcinoma.